Randal W. Scott

Randal W. Scott (board member) discloses dealings in 3 companies, chiefly BridgeBio Pharma, Inc., Invitae Corp and Talis Biomedical Corp. The record holds 11 filings, for trades running from 14 May 2021 to 17 February 2026.

In open-market terms, that means 1 purchase worth €76k on one side and 5 sales worth €269k on the other. Netting one side against the other leaves €194k of net selling. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 3 share grants and 2 option exercises.

The newest entry dates from 18 February 2026: an option exercise of €141k, in BridgeBio Pharma, Inc. The clock since the last published purchase (18 May 2021) now reads 1,979 days. Typically, a trade is published a median of 3 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.